Drug Shortage Report for RABAVERT
| Report ID | 96846 |
| Drug Identification Number | 02267667 |
| Brand name | RABAVERT |
| Common or Proper name | Rabies Vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RABIES VACCINE INACTIVATED |
| Strength(s) | 2.5UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's |
| ATC code | J07BG |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-17 |
| Estimated end date | 2020-01-02 |
| Actual end date | 2020-01-02 |
| Shortage status | Resolved |
| Updated date | 2020-01-03 |
| Company comments | |
| Health Canada comments | |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.